Published in Patient Prefer Adherence on November 28, 2013
Weakening Impact of Excessive Human Serum Albumin (eHSA) on Cisplatin and Etoposide Anticancer Effect in C57BL/6 Mice with Tumor and in Human NSCLC A549 Cells. Front Pharmacol (2016) 0.75
Overview of Albumin and Its Purification Methods. Adv Pharm Bull (2016) 0.75
A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther (1981) 69.83
Human albumin administration in critically ill patients: systematic review of randomised controlled trials. BMJ (1998) 22.62
A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med (2004) 12.79
Patient survival after human albumin administration. A meta-analysis of randomized, controlled trials. Ann Intern Med (2001) 4.96
Increased vascular permeability: a major cause of hypoalbuminaemia in disease and injury. Lancet (1985) 3.06
A paradigm for consensus. The University Hospital Consortium guidelines for the use of albumin, nonprotein colloid, and crystalloid solutions. Arch Intern Med (1995) 2.49
Human serum albumin: from bench to bedside. Mol Aspects Med (2011) 2.46
Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev (2007) 2.45
The role of albumin in critical illness. Br J Anaesth (2000) 2.33
Albumin: biochemical properties and therapeutic potential. Hepatology (2005) 2.26
[Excess mortality in critically ill patients after treatment with human albumin]. Ned Tijdschr Geneeskd (1998) 2.04
Recommendations for the use of albumin and immunoglobulins. Blood Transfus (2009) 1.75
Human albumin solution for resuscitation and volume expansion in critically ill patients. Cochrane Database Syst Rev (2004) 1.74
Human albumin solution for resuscitation and volume expansion in critically ill patients. Cochrane Database Syst Rev (2011) 1.63
Serum albumin: touchstone or totem? Anaesthesia (1998) 1.49
Review article: albumin as a drug--biological effects of albumin unrelated to oncotic pressure. Aliment Pharmacol Ther (2002) 1.29
Albumin therapy in clinical practice. Nutr Clin Pract (2005) 1.21
Safety of human albumin--serious adverse events reported worldwide in 1998-2000. Br J Anaesth (2003) 1.11
Human albumin solution for resuscitation and volume expansion in critically ill patients. Intern Emerg Med (2006) 0.93
Safety of human blood products in rare bleeding disorders in southeast of Iran. Haemophilia (2012) 0.92
How albumin administration for cirrhosis impacts on hospital albumin consumption and expenditure. World J Gastroenterol (2011) 0.86
Evaluation of serum albumin utilization in inpatient at a private hospital in Bangkok. Yakugaku Zasshi (2004) 0.82
Resuscitation using albumin in critically ill patients: research in patients at high risk of complications is now needed. BMJ (2006) 0.81
Doctors advised to take special care with human albumin. BMJ (1999) 0.79
Albumin industry launches global promotion. BMJ (2000) 0.79
[Rational use of albumin]. Harefuah (2000) 0.79
Use of albumin as a volume expander. JPEN J Parenter Enteral Nutr (1991) 0.79
Quality control of albumin solutions by size-exclusion high-performance liquid chromatography, isoelectric focusing, and two-dimensional immunoelectrophoresis. J Pharm Sci (1991) 0.79
Blood safety. Nat Med (1995) 0.78
Safety of human albumin based on spontaneously reported serious adverse events. Crit Care Med (2001) 0.78